Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome
Anne‐Laure Barbotin(Université de Lille), Paolo Giacobini(Inserm), Michael Candlish(Saarland University), Angèle Boursier(Inserm), Sowmyalakshmí Rasika(Inserm), Ulrich Boehm(Saarland University), Renaud Lopes(Laboratoire d'Automatique, Génie Informatique et Signal), Sophie Catteau-Jonard(Inserm), Federica Dal Bello(University of Turin), Jean‐Pierre Pruvo(Université de Lille), Mauro S. B. Silva(Inserm), Grégory Kuchcinski(Centre Hospitalier Universitaire de Lille), Claudio Medana(University of Turin), Danièle Mazur(Inserm), Didier Dewailly(Centre Hospitalier Universitaire Henri-Mondor), Vincent Prévot(Inserm), Pascal Pigny(Centre Hospitalier Universitaire de Lille), Qiang Yu(Fudan University), Virginie Simon(Inserm), Romain Viard(Centre Hospitalier Universitaire de Lille), Nour El Houda Mimouni(Columbia University)
Cited by 47
Related Papers
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging
|Journal of the Neurological Sciences|1993|930
European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment
|Nature Reviews Endocrinology|2015|860
Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
|Nature Medicine|2018|438
Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion
|Nature Communications|2016|390
The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
|Nature Neuroscience|2021|264